F13.229
Sedative, hypnotic or anxiolytic dependence with intoxication, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F13.229 refers to a condition where a person has developed a dependence on sedatives, hypnotics, or anxiolytics, accompanied by intoxication. These medications are commonly prescribed to manage anxiety, sleep disorders, and tension. However, misuse or prolonged use can lead to dependence, which may result in intoxication where the individual experiences altered mental and physical states. Recognizing this condition is essential to ensure appropriate management and support.
Causes & Symptoms
Clinical Causes: Long-term use of sedatives, hypnotics, or anxiolytics beyond medical recommendations. Genetic predisposition influencing susceptibility to substance dependence. Mental health conditions such as anxiety disorders or depression prompting misuse. Environmental factors like stress, trauma, or peer influence. Lack of regular medical supervision or abrupt discontinuation after prolonged use.
Key Symptoms: Drowsiness or sedation Impaired coordination and balance Confusion or disorientation Slurred speech Memory impairment Mood changes, including euphoria or depression Respiratory depression in severe cases Impaired judgment and decreased alertness
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive clinical assessment, including a detailed medical history focusing on medication use, substance intake, and behavioral patterns. Healthcare providers may perform physical examinations and request laboratory tests such as blood or urine analyses to detect the presence of sedatives, hypnotics, or anxiolytics. Screening tools and structured interviews can also aid in assessing dependence levels and intoxication severity.
Treatment Protocols: Treatment strategies focus on managing dependence and intoxication symptoms while supporting recovery. Common approaches include: - Medical detoxification under supervision to safely manage withdrawal symptoms. - Psychotherapy, including cognitive-behavioral therapy, to address underlying issues and prevent relapse. - Medication management, possibly involving alternative medications or tapered doses to reduce dependence. - Support groups and counseling services to provide ongoing emotional support. - Education on the proper use of medications to prevent future substance misuse. It’s essential that treatment plans are tailored to individual needs and administered by qualified healthcare professionals.
Clinical Advice & FAQs
Billing Guidance
Is F13.229 a billable ICD-10 code?
Yes, F13.229 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.229?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic dependence with intoxication, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
